FIV pseudovirions were generated while previously described (75)
FIV pseudovirions were generated while previously described (75). N-linked glycans are thought to shield conserved regions of the EBOV GP receptor-binding website (RBD), therefore obstructing epitopes within the RBD, we also tested whether VSVG bearing EBOV GPs that lack GP1 N-linked glycans offered effective immunity against challenge with ma-EBOV or a more distantly related disease, Sudan disease. Using a perfect/boost strategy, high doses of GP/VSVG partially or fully denuded of N-linked glycans on GP1 safeguarded mice against ma-EBOV challenge, but these mutants were no more effective than wild-type (WT) GP/VSVG and did not provide cross safety against Sudan disease. S3I-201 (NSC 74859) As reported for additional EBOV vaccine platforms, the safety conferred correlated with the amount of EBOV GP-specific Ig produced but not with the production of neutralizing antibodies. Our…